Adult Prevention of VTE in orthopedic & abdominal surgery 2.5 mg SC once daily, starting not <6 hr post-op & after hemostasis is established for at least 5-9 days, up to an additional 24 days in hip fracture surgery.
Patient at risk of thromboembolic complications 2.5 mg SC once daily for 6-14 days.
Treatment of DVT & PE >100 kg 10 mg,
50-100 kg 7.5 mg,
<50 kg 5 mg. Doses to be administered SC once daily for at least 5 days & until adequate oral anticoagulation is established (INR 2-3). Initiate concomitant treatment w/ vit K antagonists w/in 72 hr. Duration: 5-9 days.
Treatment of UA/NSTEMI 2.5 mg SC once daily for up to 8 days or until hospital discharge.
Treatment of STEMI 2.5 mg once daily, 1st dose to be given IV & subsequent doses given SC for up to 8 days or until hospital discharge.
Sign Out
